Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome
| Data(s) |
01/06/2012
|
|---|---|
| Resumo |
Cushing's syndrome (CS) is a disorder associated with significant morbidity and mortality due to prolonged exposure to high cortisol concentrations. |
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Fleseriu , M , Biller , B M K , Findling , J W , Molitch , M E , Schteingart , D E , Gross , C , SEISMIC Study Investigators & Lyons , T 2012 , ' Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome ' The Journal of clinical endocrinology and metabolism , vol 97 , no. 6 , pp. 2039-49 . DOI: 10.1210/jc.2011-3350 |
| Palavras-Chave | #Adult #Antihypertensive Agents #Blood Glucose #Blood Pressure #Body Composition #Body Weight #Cushing Syndrome #Diabetes Mellitus, Type 2 #Female #Glucose Intolerance #Hormone Antagonists #Humans #Hydrocortisone #Hypertension #Male #Middle Aged #Mifepristone #Quality of Life #Quinolines #Receptors, Glucocorticoid #Urea |
| Tipo |
article |
